Edition:
United States

Luminex Corp (LMNX.OQ)

LMNX.OQ on NASDAQ Stock Exchange Global Select Market

21.96USD
26 Jul 2016
Change (% chg)

$0.25 (+1.15%)
Prev Close
$21.71
Open
$21.75
Day's High
$22.13
Day's Low
$21.63
Volume
54,030
Avg. Vol
92,407
52-wk High
$22.85
52-wk Low
$16.16

LMNX.OQ

Chart for LMNX.OQ

About

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company has a range of instruments using its xMAP technology, including its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D... (more)

Overall

Beta: 0.29
Market Cap(Mil.): $940.93
Shares Outstanding(Mil.): 43.34
Dividend: --
Yield (%): --

Financials

  LMNX.OQ Industry Sector
P/E (TTM): 24.45 32.61 37.71
EPS (TTM): 0.89 -- --
ROI: 10.64 8.42 14.43
ROE: 10.84 12.67 15.61

BRIEF-Luminex receives FDA clearance, ce-ivd mark for Aries M1 system

* Luminex Corporation receives FDA clearance and CE-IVD mark for the Aries M1 system Source text for Eikon: Further company coverage:

Jul 06 2016

BRIEF-Luminex increases Nanosphere purchase price to $1.70/shr

* Luminex Corporation and Nanosphere, Inc. provide update on acquisition agreement

May 23 2016

BRIEF-Luminex corp to acquire Nanosphere Inc for about $58 mln

* Luminex Corporation signs definitive agreement to acquire Nanosphere, Inc.

May 16 2016

BRIEF-Luminex Q1 GAAP earnings per share $0.21

* Q1 earnings per share view $0.14 -- Thomson Reuters I/B/E/S

May 02 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Wright Reports
$75.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.